R2P METACROSS RX BD-P30200ERRecalls & reported problems
Kaneka Corporation · R2P METACROSS RX is a Percutaneous Transluminal Angioplasty (PTA) Balloon Dilatation Catheter for peripheral indications. R2P METACROSS RX is a rapid exchange (RX) type and the maximum diameter of the compatible guidewire is 0.035 inches (0.89 mm). · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04540778167070), received between Jan 22, 2021 and Jan 22, 2021 — classified as 1 injury.
The most frequently reported specific device problem is “Device Handling Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Device Handling Problem1
- Material Separation1
- Use of Device Problem1
Patient problems
- Foreign Body In Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJan 22, 2021Material Separation; Use of Device Problem; Device Handling Problem; Material Separation; Use of Device Problem; Device Handling Problem
DR. (B)(6) WAS PERFORMING A LEFT ANTERIOR TIBIAL INTERVENTION ON THE PATIENT WHEN, AT THE END OF THE CASE, HE HAD AN ISSUE WITH THE R2P METACROSS 3X200 BALLOON INVOLVED IN THIS COMPLAINT. I WAS NOT PRESENT FOR THE CASE BUT FROM MY PHONE CONVERSATION ON YESTERDAY MORNING WITH DR. SWAMY, THE CASE WAS AS FOLLOWS. DR. (B)(6) WAS ABLE TO GET ACCESS VIA THE RIGHT FEMORAL WITH A PINNACLE SHEATH, THEN IN AN UP & OVER FASHION, A 6X45 PINNACLE DESTINATION WAS ADVANCED INTO THE LEFT CFA. AN INTERVENTION OF THE LEFT AT WAS THEN COMPLETED WITH A CSI DIAMONDBACK ATHERECTOMY DEVICE OVER A VIPER WIRE. THEN, OVER THE VIPER WIRE, A 150CM SHAFT LENGTH CROSPERIO BALLOON (SIZE UNKNOWN) WAS ADVANCED TO BALLOON THE AT BUT DR. SWAMY WAS NOT ABLE TO REACH THE TARGET AREA DUE TO SHAFT LENGTH. HE THEN ASKED FOR THE 3X200 R2P METACROSS WITH THE 200CM SHAFT LENGTH IN ORDER TO REACH THE TARGET AREA. UPON ADVANCING THIS BALLOON, HE MET RESISTANCE IN THE ILIAC AREA. NOT BEING ABLE TO ADVANCE THE BALLOON PAST THIS POINT, IT WAS DECIDED TO JUST FINISH THE CASE WITHOUT THIS LAST BALLOON INFLATION ATTEMPT. HE THEN ATTEMPTED TO REMOVE THE METACROSS BUT A GREAT DEAL OF RESISTANCE WAS ENCOUNTERED. WITH FURTHER ATTEMPTS,
Patient problems: Foreign Body In Patient
MAUDE report 11213088 ↗
Other Catheter, Angioplasty, Peripheral, Transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page